8QAO

Crystal structure of TP901-1 CI-NTD89 repressor N-terminal domain

PDB DOI: https://doi.org/10.2210/pdb8QAO/pdb

Classification: DNA BINDING PROTEIN
Organism(s): Lactococcus phage TP901-1
Expression System: Escherichia coli BL21(DE3)
Mutation(s): No

Deposited: 2023-08-23 Released: 2024-02-28
Deposition Author(s): Huang, Z., Hamad, G.M., Lo Leggio, L., Varming, A.K.
Funding Organization(s): Novo Nordisk Foundation

Experimental Data Snapshot

Method: X-RAY DIFFRACTION
Resolution: 1.29 Å
R-Value Free: 0.183
R-Value Work: 0.150
R-Value Observed: 0.151

wwPDB Validation 3D Report Full Report

This is version 1.0 of the entry. See complete history.

Literature

CI:Mor interactions in the lysogeny switches of Lactococcus lactis TP901-1 and Staphylococcus aureus phi 13 bacteriophages

Varming, A.K., Huang, Z., Hamad, G.M., Rasmussen, K.K., Ingmer, H., Kilstrup, M., Lo Leggio, L.

(2024) Microbiome Res Rep

DOI: https://doi.org/10.20517/mrr.2023.50

Macromolecule Content

Total Structure Weight: 10.95 kDa
Atom Count: 887
Modelled Residue Count: 83
Deposited Residue Count: 95
Unique protein chains: 1

Macromolecules

Find similar proteins by:

(by identity cutoff) | 3D Structure

Entity ID: 1
Molecule	Chains	Sequence Length	Organism	Details	Image
CI	A	95	Lactococcus phage TP901-1	Mutation(s): 0 Gene Names: cI
UniProt
Find proteins for O48503 (Lactococcus phage TP901-1) Explore O48503 Go to UniProtKB: O48503
Entity Groups
Sequence Clusters	30% Identity50% Identity70% Identity90% Identity95% Identity100% Identity
UniProt Group	O48503
Sequence Annotations Expand
Reference Sequence

Experimental Data & Validation

Experimental Data

Method: X-RAY DIFFRACTION
Resolution: 1.29 Å
R-Value Free: 0.183
R-Value Work: 0.150
R-Value Observed: 0.151
Space Group: P 4₃ 2₁ 2

Unit Cell:

Length ( Å )	Angle ( ˚ )
a = 48.369	α = 90
b = 48.369	β = 90
c = 86.951	γ = 90

Software Package:

Software Name	Purpose
REFMAC	refinement
XDS	data reduction
XSCALE	data scaling
MOLREP	phasing

Structure Validation

View Full Validation Report

Entry History & Funding Information

Deposition Data

Released Date: 2024-02-28

Deposition Author(s):

Funding Organization	Location	Grant Number
Novo Nordisk Foundation	Denmark	--

Revision History (Full details and data files)

Version 1.0: 2024-02-28
Type: Initial release

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.